Brii Biosciences Limited
Brii Biosciences Limited focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, a recombinant protein-based HBV immunotherapeutic candidate; Elebsiran, an investigational subcutaneously administered HBV-targeting siRNA; and Tobevibart, an investigational subcutaneously administered HBV-neut… Read more
Market Cap & Net Worth: Brii Biosciences Limited (BRIBF)
Brii Biosciences Limited (PINK:BRIBF) has a market capitalization of $219.26 Million ($219.26 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #16911 globally and #6465 in its home market, demonstrating a 0.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brii Biosciences Limited's stock price $0.30 by its total outstanding shares 720776548 (720.78 Million).
Brii Biosciences Limited Market Cap History: 2022 to 2025
Brii Biosciences Limited's market capitalization history from 2022 to 2025. Data shows change from $684.74 Million to $219.26 Million (-49.74% CAGR).
Brii Biosciences Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brii Biosciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.81x
Brii Biosciences Limited's market cap is 1.81 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $684.74 Million | $51.63 Million | -$484.31 Million | 13.26x | N/A |
| 2023 | $165.71 Million | $617.00K | -$174.83 Million | 268.57x | N/A |
| 2024 | $90.46 Million | $49.94 Million | -$508.16 Million | 1.81x | N/A |
Competitor Companies of BRIBF by Market Capitalization
Companies near Brii Biosciences Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Brii Biosciences Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Brii Biosciences Limited Historical Marketcap From 2022 to 2025
Between 2022 and today, Brii Biosciences Limited's market cap moved from $684.74 Million to $ 219.26 Million, with a yearly change of -49.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $219.26 Million | +142.39% |
| 2024 | $90.46 Million | -45.41% |
| 2023 | $165.71 Million | -75.80% |
| 2022 | $684.74 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Brii Biosciences Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $219.26 Million USD |
| MoneyControl | $219.26 Million USD |
| MarketWatch | $219.26 Million USD |
| marketcap.company | $219.26 Million USD |
| Reuters | $219.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.